After a breakout 2024 edition welcoming 30,000+ visitors from 100+ countries, CPHI Middle East gears up for bigger impact in 2026. Expect extensive networking, direct market access, latest insights on regulatory developments and pharmaceutical innovations, and a comprehensive range of products and services spanning the entire pharmaceutical supply chain.
Register Now
Shots:
The EU approval of Vueway for neonates, infants, and toddlers is a milestone for pediatric imaging as it allows high-quality MRI imaging at half the GBCA dose, supporting reduced gadolinium exposure in vulnerable young patients
Vueway’s gadopiclenol demonstrates safety and diagnostic performance by offering high stability, low dissociation risk, and 2.5–4× greater relaxivity than other macrocyclic GBCAs, enabling effective imaging…
ViVE 2026 in Los Angeles convened policymakers, health system executives, payers, technologists, investors, and founders at a pivotal moment for healthcare. Across three days, discussions moved decisively from digital ambition to operational accountability.
As the official Media Partner, PharmaShots presents a comprehensive review of the sessions, speakers, and strategic insights that defined ViVE 2026.
Day…
The Evolution Summit returns May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida, bringing together leading clinical trial executives with innovative suppliers and solution providers in an invitation-only, premium setting. Expect visionary keynotes, real-world case studies, and interactive forums aligned to the most pressing challenges in clinical operations and drug development. Featured leaders include…
Shots:
GH001, an inhaled formulation of mebufotenin, is emerging as a highly differentiated therapy for treatment-resistant depression, delivering ultra-rapid and profound symptom improvement – patients come to the clinic depressed and many leave in remission already on the same day. Long term, in a Phase 2b trial, 73% of patients who completed six months were in remission—substantially higher than the…
Shots:
TULIP-SC full results reinforce efficacy and remission potential with subcutaneous Saphnelo, showing higher disease activity reduction (56.2% vs 34% placebo at Week 52), improved BICLA response, DORIS-defined remission, and reduced oral corticosteroid use, consistent with the IV formulation
Self-administration expands access and adherence, offering flexible at-home or clinic dosing, supporting earlier biologic intervention and steroid…
Next Pharma Summit is a 2-day, multi-stage conference for pharma professionals passionate about Digital, Commercial, Medical Affairs, AI, Technology, and beyond. As pharma rapidly redefines its purpose, NEXT brings together cross-functional leaders to foster smarter collaboration and create meaningful impact for customers, HCPs, and patients. One simple question guides us: Where to NEXT? Use…
Shots:
CPBIO’s expanding global footprint is powered by a science-led strategy that connects innovation, partnerships, and emerging market growth with a core goal: turning evidence-based R&D into practical solutions that improve livestock productivity, resilience, and sustainability.
The company delivers species-specific solutions across poultry, swine, ruminants, and aquaculture while following a unified R&D philosophy focused on…
Shots:
In the PharmaShots ViVE Pre-Conference Interview Series, Dr. Aasim Saeed, Founder & CEO of Amenities Health, reveals how healthcare is moving beyond hospital walls, blending clinical care with social and non-medical support to unlock better, more human-centered patient outcomes
He explores the power of digitally enabled, whole-person care models that connect health systems with…
The Pharma & Biotech Quality Summit 2026 brings together senior quality leaders to address the evolving challenges of quality management in a rapidly changing regulatory and technological landscape. Taking place in Munich on 12–13 May 2026, the summit focuses on how quality functions are adapting to AI-driven systems, advanced therapies, accelerated development timelines, and increasing…

